DK169586B1 - Histil ukendt rottemyelomacellelinie, hybridcellelinie afledt deraf, in vitro cellekultursystem og cellefusionssystem omfattende celler herfra, fremgangsmåde til fremstilling af en hybridcellelinie samt fremgangsmåde til fremstilling af monoklonale antistoffer - Google Patents

Histil ukendt rottemyelomacellelinie, hybridcellelinie afledt deraf, in vitro cellekultursystem og cellefusionssystem omfattende celler herfra, fremgangsmåde til fremstilling af en hybridcellelinie samt fremgangsmåde til fremstilling af monoklonale antistoffer Download PDF

Info

Publication number
DK169586B1
DK169586B1 DK007380A DK7380A DK169586B1 DK 169586 B1 DK169586 B1 DK 169586B1 DK 007380 A DK007380 A DK 007380A DK 7380 A DK7380 A DK 7380A DK 169586 B1 DK169586 B1 DK 169586B1
Authority
DK
Denmark
Prior art keywords
cells
cell line
rat
hybrid
immunogen
Prior art date
Application number
DK007380A
Other languages
Danish (da)
English (en)
Other versions
DK7380A (da
Inventor
Giovanni Galfre
Cesar Milstein
Bruce William Wright
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of DK7380A publication Critical patent/DK7380A/da
Application granted granted Critical
Publication of DK169586B1 publication Critical patent/DK169586B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Memories (AREA)
  • Static Random-Access Memory (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
DK007380A 1979-01-09 1980-01-07 Histil ukendt rottemyelomacellelinie, hybridcellelinie afledt deraf, in vitro cellekultursystem og cellefusionssystem omfattende celler herfra, fremgangsmåde til fremstilling af en hybridcellelinie samt fremgangsmåde til fremstilling af monoklonale antistoffer DK169586B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7900775 1979-01-09
GB7900775 1979-01-09

Publications (2)

Publication Number Publication Date
DK7380A DK7380A (da) 1980-07-10
DK169586B1 true DK169586B1 (da) 1994-12-12

Family

ID=10502406

Family Applications (1)

Application Number Title Priority Date Filing Date
DK007380A DK169586B1 (da) 1979-01-09 1980-01-07 Histil ukendt rottemyelomacellelinie, hybridcellelinie afledt deraf, in vitro cellekultursystem og cellefusionssystem omfattende celler herfra, fremgangsmåde til fremstilling af en hybridcellelinie samt fremgangsmåde til fremstilling af monoklonale antistoffer

Country Status (11)

Country Link
US (1) US4350683A (ref)
EP (1) EP0014519B1 (ref)
JP (3) JPS55113722A (ref)
AT (1) ATE2965T1 (ref)
AU (1) AU542303B2 (ref)
CA (1) CA1142466A (ref)
DE (1) DE3062558D1 (ref)
DK (1) DK169586B1 (ref)
GB (1) GB2039948B (ref)
IE (1) IE50418B1 (ref)
ZA (1) ZA797020B (ref)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3167442D1 (en) * 1980-07-07 1985-01-10 Nat Res Dev Improvements in or relating to cell lines
WO1982000364A1 (en) * 1980-07-16 1982-02-04 Jefferis R Methods of immuno-analysis using monoclonal antibodies
IL62965A0 (en) * 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
US4722896A (en) * 1981-01-26 1988-02-02 The Beth Israel Hospital Association Method for affinity purification of hybridoma antibodies
WO1982003089A1 (en) * 1981-03-06 1982-09-16 Lennox Edwin Samuel Monoclonal antibody
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4714681A (en) * 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
US4987079A (en) * 1982-07-06 1991-01-22 Wilbur D. Smith Composition and method for in vitro cell culture
US4517289A (en) * 1982-08-18 1985-05-14 Brigham And Women's Hospital Monoclonal antibodies for human tissue cross-matching
US4950598A (en) * 1982-09-22 1990-08-21 The Board Of Trustees Of The Leland Stanford Junior University Process for making T cell hybridomas
JPS60500864A (ja) * 1983-02-04 1985-06-06 ワドリ、テクナラジズ、インコーパレイティド 近縁関係にあるが別個のタンパク質間に存在する共通決定基に対して特異的なハイブリド−マ抗体の製造および特性づけ
US4508643A (en) * 1983-02-08 1985-04-02 Baxter Travenol Laboratories, Inc. Rat antibody to hCG
GB8318575D0 (en) * 1983-07-08 1983-08-10 Cobbold S P Antibody preparations
US4468346A (en) * 1983-10-27 1984-08-28 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to porcine immunoglobulins
US4469630A (en) * 1983-11-25 1984-09-04 J. T. Baker Chemical Co. Purification of monoclonal antibodies
US4596769A (en) * 1984-03-05 1986-06-24 Temple University Monoclonal antibodies to peptidoglycan and methods of preparing same
US4604235A (en) * 1984-05-23 1986-08-05 J. T. Baker Chemical Company Purification of monoclonal antibodies
JPS60258128A (ja) * 1984-06-06 1985-12-20 Kyowa Hakko Kogyo Co Ltd ラツトモノクロ−ナル抗体
US4791068A (en) * 1984-06-22 1988-12-13 Scripps Clinic And Research Foundation Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators
JPS6179164A (ja) * 1984-09-26 1986-04-22 Amano Pharmaceut Co Ltd 抗原抗体反応の短縮方法
US4757018A (en) * 1985-02-11 1988-07-12 Hazleton Biotechnologies, Inc. Myeloma cell lines and uses thereof
US4814275A (en) * 1985-05-13 1989-03-21 E.I. Dupont De Nemours And Company Monoclonal hybridoma antibody specific for a human epithelial antigen
CA1302919C (en) * 1985-07-03 1992-06-09 Robert T. Buckler Histamine derivatives, immunogen conjugates and antibodies raised thereto
US5292636A (en) * 1986-03-31 1994-03-08 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
JP2520681B2 (ja) * 1986-08-04 1996-07-31 ザ ユニバーシティ オブ ニュー サウス ウェールズ 生合成のヒトの成長ホルモン製品
US6610654B2 (en) 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
WO1994022915A1 (en) * 1993-03-31 1994-10-13 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
EP2264166B1 (en) 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
WO2001029246A1 (fr) 1999-10-19 2001-04-26 Kyowa Hakko Kogyo Co., Ltd. Procede de production d'un polypeptide
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
AU2003236017B2 (en) 2002-04-09 2009-03-26 Kyowa Kirin Co., Ltd. Drug containing antibody composition
US7340957B2 (en) 2004-07-29 2008-03-11 Los Alamos National Security, Llc Ultrasonic analyte concentration and application in flow cytometry
CA2607177A1 (en) * 2004-09-10 2006-03-23 Brij B. Saxena Betulinol derivatives as anti-cancer agents
JP4898710B2 (ja) 2005-02-11 2012-03-21 メモリアル スローン−ケタリング キャンサー センター 薬剤耐性ｅｇｆｒ突然変異体を検出するための方法および組成物
US7835000B2 (en) 2006-11-03 2010-11-16 Los Alamos National Security, Llc System and method for measuring particles in a sample stream of a flow cytometer or the like
WO2008122051A1 (en) 2007-04-02 2008-10-09 Acoustic Cytometry Systems, Inc. Methods and devices for enhanced analysis of field focused cells and particles
US8083068B2 (en) * 2007-04-09 2011-12-27 Los Alamos National Security, Llc Apparatus for separating particles utilizing engineered acoustic contrast capture particles
US7837040B2 (en) * 2007-04-09 2010-11-23 Los Alamos National Security, Llc Acoustic concentration of particles in fluid flow
US8528406B2 (en) 2007-10-24 2013-09-10 Los Alamos National Security, LLP Method for non-contact particle manipulation and control of particle spacing along an axis
US8263407B2 (en) 2007-10-24 2012-09-11 Los Alamos National Security, Llc Method for non-contact particle manipulation and control of particle spacing along an axis
US8266950B2 (en) 2007-12-19 2012-09-18 Los Alamos National Security, LLP Particle analysis in an acoustic cytometer
US8714014B2 (en) 2008-01-16 2014-05-06 Life Technologies Corporation System and method for acoustic focusing hardware and implementations
CN108882701A (zh) 2016-03-28 2018-11-23 东洋制罐集团控股株式会社 分散液、其生产方法和铜化合物颗粒
JP6984122B2 (ja) * 2016-12-15 2021-12-17 東洋製罐グループホールディングス株式会社 抗ウイルス性を有する分散液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
ZA783261B (en) * 1977-06-15 1979-06-27 Wistar Inst Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies

Also Published As

Publication number Publication date
IE50418B1 (en) 1986-04-16
JPH032515B2 (ref) 1991-01-16
GB2039948A (en) 1980-08-20
ATE2965T1 (de) 1983-04-15
JPH052318B2 (ref) 1993-01-12
IE800032L (en) 1980-07-09
JPS55113722A (en) 1980-09-02
JPH05276983A (ja) 1993-10-26
JPH02227096A (ja) 1990-09-10
DK7380A (da) 1980-07-10
CA1142466A (en) 1983-03-08
ZA797020B (en) 1981-08-26
DE3062558D1 (en) 1983-05-11
US4350683A (en) 1982-09-21
AU5445680A (en) 1980-07-17
GB2039948B (en) 1983-04-07
EP0014519B1 (en) 1983-04-06
AU542303B2 (en) 1985-02-14
EP0014519A2 (en) 1980-08-20
EP0014519A3 (en) 1981-01-07
JP2648419B2 (ja) 1997-08-27

Similar Documents

Publication Publication Date Title
DK169586B1 (da) Histil ukendt rottemyelomacellelinie, hybridcellelinie afledt deraf, in vitro cellekultursystem og cellefusionssystem omfattende celler herfra, fremgangsmåde til fremstilling af en hybridcellelinie samt fremgangsmåde til fremstilling af monoklonale antistoffer
US4472500A (en) Rat myeloma cell lines
US5643736A (en) Monoclonal antibodies for human osteogenic cell surface antigens
US4468346A (en) Monoclonal antibodies to porcine immunoglobulins
DK154769B (da) Monoklonalt antistof, fremstilling heraf, hybridomacellelinie til anvendelse ved fremstilling heraf samt fremgangsmaader til anvendelse heraf
DK154086B (da) Monoklonalt antistof, fremstilling deraf, hybridomacellelinie til anvendelse ved fremstilling heraf samt fremgangsmaade til diagnose ved anvendelse heraf
US4517289A (en) Monoclonal antibodies for human tissue cross-matching
EP0102601A2 (en) Monoclonal antibody, a process for its production and the use of this monoclonal antibody
EP0057107A2 (en) Method of manufacturing monoclonal antibodies and cells capable of manufacturing such antibodies
US5024946A (en) Human monoclonal antibody to antigen of gastric cancer and B-cell line for producing this antibody, method for preparing this B-cell line and antibody, antigen and method of preparation of this antigen
CA1213227A (en) Human nonsecretory plasmacytoid cell line
Letchworth Methods for production of monoclonal antibodies
EP0077571A2 (en) Process for producing a lymphokine
GB2079313A (en) Improvements in or relating to rat myeloma cell lines
JP3043023B2 (ja) ハイブリドーマ
SU1595902A1 (ru) Штамм гибридных культивируемых клеток животных MUS мUSсULUS L, используемый дл получени моноклональных антител к антигену СД38 кортикальных тимоцитов
RU1801117C (ru) Способ получения монокло- нального антитела к моноклональному антителу к белку т4 лимфоцита человека, культивируемая клетка гибридомы jthfs-про- дуцентмоноклонального антитела к моноклональному антителу к белку т4 лимфоцита чело- века, культивируемая клетка гибридомы jti-if3-f5 - продуцент моноклонального антитела к моноклональному антителу к белку т4 лимфоцитачеловека, культивируемая клетка гибридомы jti-id7 - про- дуцент моноклонального антитела к моноклональному антителу к белку т4 лимфоцита человека, культивируемая клетка гибридомы jt2-n15 - продуцент моноклонального антитела к моноклональному антителу к белку т4 лимфоцитачеловека
USRE33252E (en) Hybridoma antibody which inhibits Interleukin 2 activity
Litwin et al. Change in Ig Expression of a Human Lymphoblastoid Line During Long‐Term Culture
US5849539A (en) Thymidine kinase-lacking ouabain-resistant chicken hybridoma
RU1776691C (ru) Штамм гибридных культивируемых клеток животных MUS мUSсULUS L, - продуцент моноклональных антител против J @ Е человека
Martin et al. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma
JPH01257477A (ja) 安定なウサギ−マウスハイブリドーマ及びその分泌物
WO1986002366A1 (en) Aotus interspecies hybridomas and monoclonal receptors produced thereby
WO2003083072A2 (en) In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states